Table 2.
The number of positive test results in RT-PCR testing and the number of confirmed ones.
| N. | First author | N. of total cases | Number of total confirmed patients | N. of patients confirmed with the first RT-PCR test (perc.a) | N. of patients confirmed with the second RT-PCR test (perc.b) | N. of patients confirmed with the third RT-PCR test (perc.c) | N. of patients confirmed with the fourth RT-PCR test (perc.d) | N. of Patients confirmed later (perc.e) |
|---|---|---|---|---|---|---|---|---|
| 1 | Tao Ai36 | 1014 | 909 | 343 (37.7%) | 205 (22.6%) | 45 (5%) | 8 (0.9%) | 308 (33.9%) |
| 2 | Xingzhi Xie44 | 167 | 167 | 162 (97%) | 2 (1.2%) | 2 (1.2%) | 0 (0%) | 1 (0.6%) |
| 3 | Jian Wu22 | 80 | 80 | 41 (51.2%) | 30 (37.5%) | 9 (11.3%) | 0 (0%) | 0 (0%) |
| 4 | Anne Kimball48 | 82 | 76 | 23 (30%) | _f | _ | _ | 53 (70%) |
| 5 | Li Yuanyuan49 | 54 | 54 | 31 (57%) | _ | _ | _ | 23 (42.6%) |
| 6 | Chenyao Lin50 | 52 | 52 | 23 (44%) | _ | _ | _ | 29 (56%) |
| 7 | Yicheng Fang44 | 51 | 51 | 36 (70.6%) | 12 (23.6%) | 2 (7.8%) | 1 (2%) | 0 (0%) |
| 8 | Qi Zhong32 | 49 | 49 | 13 (26.5%) | _ | _ | _ | 36 (73.5%) |
| 9 | Lorenzo Azzi51 | 25 | 25 | 23 (92%) | 2 (8%) | - | - | 0 (0%) |
| 10 | Xiaoqing Wu43 | 23 | 23 | 19 (83%) | _ | _ | _ | 4 (17%) |
| 11 | Qing Chen52 | 9 | 9 | 9 (100%) | _ | _ | _ | 0 (0%) |
| 12 | Li-Na Ji27 | 7 | 5 | 4 (80%) | _ | _ | _ | 1 (20%) |
| 13 | Jasper Fuk-Woo Chan16 | 6 | 5 | 4 (80%) | _ | _ | _ | 1 (20%) |
| 14 | YajunYuan53 | 6 | 6 | 6 (100%) | _ | _ | _ | 0 (0%) |
| 15 | Wei Li18 | 5 | 5 | 4 (80%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (20%) |
| 16 | Zohre Khodamoradi54 | 4 | 4 | 4 (100%) | _ | _ | _ | 0 (0%) |
| 17 | Li Ni55 | 3 | 3 | 1 (33.3%) | 0 (0%) | 0 (0%) | _ | 2 (66.7%) |
| 18 | Junqing Xu 24 | 3 | 3 | 0 (0%) | 2 (67%) | 1 (33%) | _ | 0 (0%) |
| 19 | Yuanzhe Li41 | 2 | 2 | 1 (50%) | 1 (50%) | _ | _ | 0 (0%) |
| 20 | Michal Paret56 | 2 | 2 | 2 (100%) | _ | _ | _ | 0 (0%) |
| 21 | Zhi-Qun Mao57 | 2 | 2 | 2 (100%) | _ | _ | _ | 0 (0%) |
| 22 | Wendong Hao44 | 1 | 1 | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) | 0 (0%) |
| 23 | Peikai Huang40 | 1 | 1 | 0 (0%) | 0 (0%) | 1 (100%) | _ | 0 (0%) |
| 24 | Jinrong Qu58 | 1 | 1 | 1 (100%) | _ | _ | _ | 0 (0%) |
| 25 | Xavier Marchand-Senécal59 | 1 | 1 | 1 (100%) | _ | _ | _ | 0 (0%) |
| 26 | Takeshi Arashiro55 | 1 | 1 | 1 (100%) | _ | _ | _ | 0 (0%) |
| 27 | Hao Feng30 | 1 | 1 | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) |
| 28 | Ryota Hase60 | 1 | 1 | 0 (0%) | 1 (100%) | _ | _ | 0 (0%) |
| 29 | Yosuke Hirotsu61 | 1 | 1 | 1 (100%) | _ | _ | _ | 0 (0%) |
| 30 | E. Kalafat62 | 1 | 1 | 0 (0%) | 1 (100%) | _ | _ | 0 (0%) |
| 31 | Mojtaba Kamali Aghdam63 | 1 | 1 | 1 (100%) | _ | _ | _ | 0 (0%) |
| 32 | Parisa Karami64 | 1 | 1 | 1 (100%) | _ | _ | _ | 0 (0%) |
| 33 | Dasheng Li7 | 1 | 1 | 0 (0%) | 0 (0%) | 1 (100%) | _ | 0 (0%) |
| 34 | Ding-feng Lv65 | 1 | 1 | 0 (0%) | 0 (0%) | 1 (100%) | 1 (100%) | 1 (100%) |
| 35 | Chaisith Sivakorn66 | 1 | 1 | 0 (0%) | 1 (100%) | _ | _ | 0 (0%) |
aNumber of primarily confirmed patients divided total confirmed patients.
bNumber of secondary confirmed patients divided total confirmed patients.
cNumber of thirdly confirmed patients divided total confirmed patients.
dNumber of fourthly confirmed patients divided total confirmed patients.
eNumber of patients who were confirmed later divided by total confirmed patients.
fThis means the test has not been conducted or reported.